Isabelle Girault

3.1k citations

39 papers · 1.2k indexed · 1 hit paper · h-index 16

Co-authors: Alain Venet Camille Lécuroux Martine Sinet Caroline Robert Stéphan Vagner Laurence Meyer Alexander M.M. Eggermont Federico Simonetta
Topics: Immune Cell Function and Interaction (11 papers)HIV Research and Treatment (10 papers)Cancer Immunotherapy and Biomarkers (10 papers)
Cited by: Virology Immunology Oncology
Journals: Nature Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: France United States Belgium

In The Last Decade

Isabelle Girault

36 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

2022 162 citations Lucas Blanchard, Elisabeth Bellard et al. Cancer Cell profile →

Peers

Countries citing papers authored by Isabelle Girault

Since Specialization

Citations

This map shows the geographic impact of Isabelle Girault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Girault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Girault more than expected).

Fields of papers citing papers by Isabelle Girault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Girault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Girault. The network helps show where Isabelle Girault may publish in the future.

Co-authorship network of co-authors of Isabelle Girault

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Girault. A scholar is included among the top collaborators of Isabelle Girault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Girault. Isabelle Girault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	DOP031 Anti-IL-7 receptor plus anti-IL12/23 combination induces complete histological normalization in chronic colitis 2025 ·Journal of Crohn s and Colitis ·(unknown),(unknown),(unknown),(unknown),(unknown),Sabrina Pengam,Donald W. Marion,Isabelle Girault,Nicolas Poirier	0
2	493 Identification of different classes of antagonist monoclonal antibodies targeting the myeloid checkpoint CLEC-1 and their associated anti-tumoralin vivoefficacies in humanized preclinical models 2023 ·SHILAP Revista de lepidopterología ·Irène Baccelli,Caroline Mary,(unknown),(unknown),(unknown),Géraldine Teppaz,Emmanuelle Wilhelm,Isabelle Girault,Vanessa Gauttier,Virginie Thépenier,(unknown),Kévin Biteau,(unknown),(unknown),(unknown),(unknown),Elise Chiffoleau,Nicolas Poirier	1
3	ChemR23 activation reprograms macrophages toward a less inflammatory phenotype and dampens carcinoma progression 2023 ·Frontiers in Immunology ·(unknown),Vanessa Gauttier,(unknown),(unknown),(unknown),Judith Fresquet,(unknown),Isabelle Girault,(unknown),(unknown),Caroline Mary,Philippe Juin,Nicolas Poirier,Sophie Barillé‐Nion,Christophe Blanquart	13
4	Abstract 2129: Predictive response biomarkers from Phase I clinical trial of a SIRPalpha inhibitor BI765063, stand-alone and in combination with ezabenlimab, a PD1 inhibitor, in patients with advanced solid tumors 2023 ·Cancer Research ·Stéphane Champiat,Philippe A. Cassier,Nuria Kotecki,Carlos Gomez-Roca,(unknown),(unknown),Antoîne Italiano,Mabrouk Elgadi,(unknown),Isabelle Girault,Nina Salabert,(unknown),Nicolas Poirier,B. Vasseur,(unknown),(unknown),Françoise Bono,Jean‐Pierre Delord	2
5	Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapybreakdown → 2022 ·Cancer Cell ·(unknown),(unknown),(unknown),(unknown),Lucas Blanchard,Elisabeth Bellard,Krystle Veerman,S. Bettini,Fanny Lafouresse,(unknown),(unknown),Séverine Le Roy,Isabelle Girault,(unknown),Frédéric Martins,Jean‐Yves Scoazec,Nathalie Ortéga,Caroline Robert,Jean‐Philippe Girard	162
6	Abstract 1766: Triggering the resolution of inflammation with agonistic anti-ChemR23 antibody dampens inflammation-driven carcinogenesis 2021 ·Cancer Research ·Vanessa Gauttier,(unknown),(unknown),Kévin Biteau,Isabelle Girault,Lyssia Belarif,Géraldine Teppaz,Caroline Mary,Virginie Thépenier,Christophe Blanquart,Sophie Barillé‐Nion,Nicolas Poirier	1
7	In situ detection of the eIF4F translation initiation complex in mammalian cells and tissues 2021 ·STAR Protocols ·Shensi Shen,Isabelle Girault,Hélène Malka-Mahieu,Caroline Robert,Stéphan Vagner	1
8	Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma 2019 ·Cancer Immunology Immunotherapy ·Antoine Moya‐Plana,Ruth Gabriela Herrera Gómez,Caroline Rossoni,Laurent Dercle,Samy Ammari,Isabelle Girault,Séverine Le Roy,Jean‐Yves Scoazec,Stéphan Vagner,François Janot,Alexander M.M. Eggermont,Caroline Robert	52
9	USE OF A COMPUTER TOOL IN SCIENCE TEACHING TO SUPPORT THE DESIGN OF EXPERIMENTS 2019 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown),Isabelle Girault,Cédric d’Ham,(unknown)	0
10	Secondary Tumors Arising in Patients Undergoing BRAF Inhibitor Therapy Exhibit Increased BRAF–CRAF Heterodimerization 2016 ·Cancer Research ·Lise Boussemart,Isabelle Girault,Hélène Malka-Mahieu,Christine Mateus,Émilie Routier,(unknown),Nyam Kamsu-Kom,M. Thomas,Gorana Tomasic,Sandrine Agoussi,(unknown),Mélanie Laporte,Ludovic Lacroix,Alexander M.M. Eggermont,Andréa Cavalcanti,Florent Grange,Julien Adam,Stéphan Vagner,Caroline Robert	33
11	A dose escalation phase 1 study of radiotherapy (RT) in combination with anti-cytotoxic-T-lymphocyte-associated antigen 4 (CTLA-4) monoclonal antibody ipilimumab (Ipi) in patients (pts) with metastatic melanoma 2016 ·Annals of Oncology ·C. Boutros,Christine Mateus,Émilie Routier,Salem Chouaı̈b,C. Libenciuc,(unknown),Isabelle Girault,Caroline Caramella,(unknown),Stéphan Vagner,Yungan Tao,Nathalie Chaput,Julien Adam,J.C. Soria,Alexander M.M. Eggermont,Éric Deutsch,Caroline Robert	2
12	eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies 2014 ·Nature ·Lise Boussemart,Hélène Malka-Mahieu,Isabelle Girault,Delphine Allard,Oskar Hemmingsson,Gorana Tomasic,M. Thomas,Christine Basmadjian,Nigel Ribeiro,Frédéric Thuaud,Christina Mateus,Émilie Routier,Nyam Kamsu-Kom,Sandrine Agoussi,Alexander M.M. Eggermont,Laurent Désaubry,Caroline Robert,Stéphan Vagner	261
13	Targeting the Deregulated Spliceosome Core Machinery in Cancer Cells Triggers mTOR Blockade and Autophagy 2013 ·Cancer Research ·Virginie Quidville,Samar Alsafadi,Aïcha Goubar,Frédéric Commo,Véronique Scott,Catherine Pioche‐Durieu,Isabelle Girault,Sonia Baconnais,Éric Le Cam,Vladimir Lazar,Suzette Delaloge,Mahasti Saghatchian,Patricia Pautier,Philippe Morice,(unknown),Stéphan Vagner,Fabrice André	75
14	Zinc chelation: a metallothionein 2A’s mechanism of action involved in osteosarcoma cell death and chemotherapy resistance 2013 ·Cell Death and Disease ·(unknown),Zahia Hamidouche,Isabelle Girault,Ana Patiño‐García,Fernando Lecanda,Pierre J. Marie,Olivia Fromigué	50
15	CD8 T-Cells from Most HIV-Infected Patients Lack Ex Vivo HIV-Suppressive Capacity during Acute and Early Infection 2013 ·PLoS ONE ·Camille Lécuroux,Isabelle Girault,Antoine Chéret,Pierre Versmisse,(unknown),Laurence Meyer,Christine Rouzioux,Gianfranco Pancino,Alain Venet,Asier Sáez‐Cirión	15
16	Acute Plasma Biomarkers of T Cell Activation Set-Point Levels and of Disease Progression in HIV-1 Infection 2012 ·PLoS ONE ·Anne-Sophie Liovat,Marie-Anne Rey-Cuillé,Camille Lécuroux,Béatrice Jacquelin,Isabelle Girault,Gaël Petitjean,(unknown),Alain Venet,Françoise Barré‐Sinoussi,Pierre Lebon,Laurence Meyer,Martine Sinet,Michaela Müller‐Trutwin	120
17	NKG2D Expression on HIV-Specific CD8+ T cells Is Reduced in Viremic HIV-1–Infected Patients but Maintained in HIV Controllers 2012 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Camille Lécuroux,Asier Sáez‐Cirión,Nicolas Noël,(unknown),Isabelle Girault,Sophie Caillat‐Zucman,Daniel Scott‐Algara,Alain Venet,Olivier Lambotte	4
18	Early and Long-Lasting Alteration of Effector CD45RA−Foxp3high Regulatory T-Cell Homeostasis During HIV Infection 2012 ·The Journal of Infectious Diseases ·Federico Simonetta,Camille Lécuroux,Isabelle Girault,Cécile Goujard,Martine Sinet,Olivier Lambotte,Alain Venet,Christine Bourgeois	48
19	Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells 2009 ·AIDS ·Camille Lécuroux,Isabelle Girault,(unknown),Alejandra Urrutia,Cécile Goujard,Laurence Meyer,Olivier Lambotte,Marie‐Laure Chaix,(unknown),Brigitte Autran,Martine Sinet,Alain Venet	18
20	Immunodetection of 3-nitrotyrosine in the liver of zymosan-treated rats with a new monoclonal antibody: comparison to analysis by HPLC 2001 ·Free Radical Biology and Medicine ·Isabelle Girault,Alexander E. Karu,(unknown),Mary Helen Barcellos‐Hoff,Tory M. Hagen,(unknown),Bruce N. Ames,Stephan Christen,Mark K. Shigenaga	22

About Isabelle Girault

Isabelle Girault is a scholar working on Virology, Immunology and Oncology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), HIV Research and Treatment (10 papers) and Cancer Immunotherapy and Biomarkers (10 papers). The work is most often cited by research in Virology (319 citations), Immunology (488 citations) and Oncology (330 citations). Isabelle Girault has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Alain Venet, Camille Lécuroux, Martine Sinet, Caroline Robert, Stéphan Vagner, Laurence Meyer, Alexander M.M. Eggermont, Federico Simonetta, Christine Bourgeois and Hélène Malka-Mahieu. Their work appears in journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact